Floatz logo

Therapeutic Asset Ratings

13,155 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Abemaciclib
Metastatic Prostate Carcinoma
Praful Ravi, MB BCHir, MRCPP2B (59)
Abemaciclib
Triple-Negative Breast Carcinoma
UNC Lineberger Comprehensive Cancer CenterP2B (59)
Adavosertib
Exocrine Pancreatic Carcinoma
National Cancer Institute (NCI)P2B (59)
Adriamycin
Colorectal Neoplasm
Eisai Inc.P2B (59)
Adriamycin
Refractory Malignant Neoplasm
BeOne MedicinesP2B (59)
Alirocumab
Cerebral Atherosclerosis
Chang Gung Memorial HospitalP2B (59)
Alpelisib
Ovarian Carcinoma
National Cancer Institute (NCI)P2B (59)
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit
Myelodysplastic Syndrome With Excess Blasts
M.D. Anderson Cancer CenterP2B (59)
Astarabine
Acute Myeloid Leukemia
BioSight Ltd.P2B (59)
Atezolizumab
Biliary Tract Cancer
Replimune, Inc.P2B (59)
Atezolizumab
Head And Neck Cancer
Centre Georges Francois LeclercP2B (59)
Atezolizumab
Non-Hodgkin Lymphoma
Genentech, Inc.P2B (59)
Atezolizumab
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI)P2B (59)
Atezolizumab
Sarcoma
Cancer Research UKP2B (59)
Avutometinib
Lung Cancer
Emory UniversityP2B (59)
Azacitidine
Mixed Phenotype Acute Leukemia
Therapeutic Advances in Childhood Leukemia ConsortiumP2B (59)
Azacytidine
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
City of Hope Medical CenterP2B (59)
Azeliragon
Glioblastoma
Washington University School of MedicineP2B (59)
Balstilimab
Malignant Pancreatic Neoplasm
Nelum CorpP2B (59)
Bendamustine
B-Cell Non-Hodgkin Lymphoma
Swiss Cancer InstituteP2B (59)
Bendamustine
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2B (59)
Bet Bromodomain Inhibitor Zen-3694
Metastatic Prostate Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP2B (59)
Binimetinib
Refractory Malignant Neoplasm
N.N. Petrov National Medical Research Center of OncologyP2B (59)
Boserolimab
Non-Small Cell Lung Carcinoma
Merck Sharp & Dohme LLCP2B (59)
Cabozantinib
Metastatic Melanoma
National Cancer Institute (NCI)P2B (59)
Showing 2276 to 2300 of 13,155 assets
PreviousPage 92 of 527Next